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Summary
 
We have used interleukin-10 (IL-10) gene knockout mice (IL-10
 
2
 
/
 
2
 
) to examine the role of
endogenous IL-10 in allergic lung responses to 
 
Aspergillus fumigatus
 
 Ag. In vitro restimulated
lung cells from sensitized IL-10
 
2
 
/
 
2
 
 mice produced exaggerated amounts of IL-4, IL-5, and in-
terferon-
 
g
 
 (IFN-
 
g
 
) compared with wild-type (WT) lung cells. In vivo, the significance of IL-10
in regulating responses to repeated 
 
A. fumigatus
 
 inhalation was strikingly revealed in IL-10
 
2
 
/
 
2
 
outbred mice that had a 50–60% mortality rate, while mortality was rare in similarly treated
WT mice. Furthermore, IL-10
 
2
 
/
 
2
 
 outbred mice exhibited exaggerated airway inflammation
and heightened levels of IL-5 and IFN-
 
g
 
 in bronchoalveolar lavage (BAL) fluids. In contrast,
the magnitude of the allergic lung response was similar in intranasally (i.n.) sensitized IL-10
 
2
 
/
 
2
 
and wild-type mice from a different strain (C57BL/6). Using a different route of priming (in-
traperitoneal) followed by one i.n. challenge we found that IL-10
 
2
 
/
 
2
 
 C57BL/6 mice had
heightened eosinophilic airway inflammation, BAL–IL-5 levels, and numbers of 
 
ab
 
T cells in
the lung tissues compared with WT mice. We conclude that IL-10 can suppress inflammatory
Th2-like lung responses as well as Th1-like responses given the constraints of genetic back-
ground and route of priming.
 
A
 
spergillus fumigatus
 
 is an opportunistic fungal pathogen
for humans and animals causing lung hypersensitivities
with and without life-threatening growth in the lungs or
sinuses (reviewed in reference 1). In humans, lung hyper-
sensitivity to 
 
A. fumigatus
 
 can occur in different forms (2).
The two opposite extremes are asthma with increased serum
IgE titers (2) and hypersensitivity pneumonitis with in-
creased serum IgG and low IgE titers (3, 4). Clinically,
asthma presents as recurrent bouts of dyspnoea due to
bronchoconstriction, whereas hypersensitivity pneumoni-
tis is characterized by bouts of dyspnoea accompanied by in-
fluenza-like symptoms (e.g., fever, fatigue). Immunologi-
cally, asthma has been associated with an exaggerated Th2
response promoting IgE synthesis, eosinophil infiltration,
and activation of mast cells in the lungs (reviewed in refer-
ence 5). In contrast, hypersensitivity pneumonitis is charac-
terized by neutrophil influx into the lungs at the acute phase
and T cell and macrophage influx during the chronic phase of
the disease (6). It is thought to be caused by excessive mac-
rophage activation (6) due to an immune complex–medi-
ated Arthus reaction (reviewed in reference 3) together
with a CD4 T cell response probably mediated by Th1 cy-
tokines (7). Most patients who are hypersensitive to 
 
A. fu-
migatus
 
 suffer from a disease called allergic bronchopulmo-
nary aspergillosis (ABPA)
 
1
 
. The main features of this disease
are activated Th2 cells (8) and asthma; however, IgG-medi-
ated Arthus reactions (2) and autoimmune reactions (9) can
also contribute to the pathogenesis.
Because IL-10 is constitutively produced by bronchial
epithelial cells (10) and potentially inhibits cytokine pro-
duction by cultured alveolar macrophages and lung den-
dritic cells (11–15), there has been considerable interest in
the role of IL-10 in regulating pulmonary immune re-
sponses. IL-10 has been shown to suppress acute inflamma-
tion induced by the formation of antigen–antibody com-
plexes in the lungs of mice (localized Arthus reaction) (16).
 
1
 
Abbreviations used in this paper:
 
 ABPA, allergic bronchopulmonary as-
pergillosis; ACh, Acetylcholine; BAL, bronchoalveolar lavage; IL-10
 
2
 
/
 
2
 
mice, IL-10 gene knockout mice; i.n., intranasal; PC200, provocative
challenge dose 200; WT mice, wild-type mice.
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However, little information is available concerning a role
for IL-10 in regulating Th2-like responses leading to asth-
matic lung hypersensitivity reactions. Analysis of broncho-
alveolar lavage (BAL) fluids from asthmatic patients have
produced puzzling results as they showed increased IL-10
mRNA expression by BAL cells (17) but diminished IL-10
protein in BAL fluids (18). Based on the results of numerous
murine studies, it has been proposed that IL-10 enhances
Th2 responses, albeit indirectly, by inhibiting an accompa-
nying Th1 response (reviewed in reference 19). Although
these studies evaluated antigen-induced responses in organs
other than the lung, the general findings would suggest that
IL-10 may actually contribute to the preferential genera-
tion of a Th2 response deemed responsible for allergic pul-
monary reactions. On the other hand, a recent study showed
that mice sytemically primed with OVA exhibited dimin-
ished lung eosinophilia upon rechallenge with aerosolized
OVA if IL-10 was also administered (20). These latter stud-
ies show that IL-10 is at least capable of suppressing eosino-
philic inflammation (Th2-like response) under certain in
vivo conditions and thus may have some therapeutic value.
The present study has focused on the role of endogenous
IL-10 in regulating allergic pulmonary reactions. Previous
studies have shown that sensitization of BALB/c mice with
 
A. fumigatus
 
 Ag normally induces a strong Th2-like re-
sponse resulting in pulmonary eosinophilia and elevated se-
rum IgE levels (21, 22). We have compared the responses
of IL-10
 
2
 
/
 
2
 
 and wild-type (WT) mice after repeated chal-
lenges with 
 
A. fumigatus
 
 Ag to identify altered reactions that
may occur in the absence of IL-10 regulation (i.e., cytokine
production, airway inflammation, airway hyperresponsive-
ness, and serum antibody titers). Furthermore, different
routes of sensitization and strains of mice were used as these
variables have been shown to influence the type and/or
magnitude of an immune response elicited in other experi-
mental systems.
 
Materials and Methods
 
Animals.
 
IL-10
 
2
 
/
 
2
 
 outbred mice, generated on a mixed
C57BL/6 
 
3
 
 129Sv F2 background (23), and outbred WT litter-
mate mice were derived by cesarean section under specific patho-
gen-free conditions at Simonsen Laboratory (Gilroy, CA) and main-
tained in micro isolator cages in the animal facility at DNAX
Research Institute (Palo Alto, CA) (24). Inbred C57BL/6 IL-10
 
2
 
/
 
2
 
mice were derived from outbred IL-10
 
2
 
/
 
2
 
 mice by 12 back-
crosses to C57BL/6 WT mice and interbreeding of heterozygous
offspring. Heterozygous littermates and homozygous WT C57BL/6
mice purchased from The Jackson Laboratory (Bar Harbor, ME)
were used as controls. All of the mice were maintained in the
DNAX animal facility under identical conditions. IL-10
 
2
 
/
 
2
 
, WT,
and sentinel mice were periodically examined by the Research
Animal Diagnostic and Investigative Laboratory (University of Mis-
souri, Columbia, MO). Bacterial cultures, parasitological exami-
nations, serologic tests, and special histological stains were nega-
tive for known murine viral and bacterial pathogens. 6–9-wk-old
mice were used in the experiments.
 
A. fumigatus Ag.
 
The 
 
A. fumigatus
 
 Ag preparation is a mix-
ture of culture filtrate and mycelial extract prepared free of living
organisms as described (21). This complex preparation has been
particularly useful in detecting serum antibody levels and skin re-
activity in human patients (25). Two batches of 
 
A. fumigatus
 
 Ag
with equivalent activities (lot numbers 5323R1, 5325) were ali-
quotted at a concentration of 10 mg/ml and stored at 
 
2
 
70
 
8
 
C for
use in all the experiments described herein. The LPS content of
the Ag extracts was less than 0.2 EU/100 
 
m
 
g of Ag when tested
with the Limulus Amebocyte Lysate test (BioWhittaker, Walk-
ersville, MD).
 
Sensitization with A. fumigatus Ag.
 
Wild-type and IL-10
 
2
 
/
 
2
 
mice were repeatedly primed either i.p. or intranasally (i.n.) fol-
lowed by a final i.n. challenge (21). In all cases, 100 
 
m
 
g of Ag was
used after dilution in PBS so as to deliver a total volume of 50 or
200 
 
m
 
l for i.n. or i.p. administration, respectively. All mice re-
ceiving an i.n. challenge were anaesthetized with isofluorane and
held upright until all of the Ag administered onto their nostrils
with a micropipette tip was inhaled.
 
Airway Inflammation.
 
Airway inflammation was analyzed us-
ing BAL. Lungs were lavaged three times with 1 ml of PBS. Ap-
proximately 2.4 ml of fluid was routinely recovered. Total cell
numbers were determined using a hemacytometer. Differential
cell counts were obtained from BAL cells spun onto slides with a
cytocentrifuge and treated with Wright-Giemsa stain (Sigma Chem.
Co., St. Louis, MO). 400 cells were enumerated. Absolute num-
bers of specific cell types present in BAL fluids were calculated
from the recovered volume, total cell count, and the relative fre-
quency of that particular cell type. BAL supernatants were col-
lected by centrifugation and stored at 
 
2
 
70
 
8
 
C until assayed for cy-
tokine levels.
 
In Vitro Restimulation of Lung Cells.
 
Lung tissue, trimmed of
bronchial lymph nodes and trachea, were minced through a ster-
ile no. 100 steel mesh screen (Tylinter, Inc., Mentor, OH) into a
petri dish containing 5 ml of HBSS and antibiotics. The lung cells
were washed once with HBSS and resuspended at 8 
 
3
 
 10
 
6
 
 cells/
ml in medium (RPMI-1640 supplemented with 10% FCS, 50 mM
2-ME, 100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin). 500 
 
m
 
l
to 1 ml of lung cell suspension was pipetted into three sets of 24-well
flat-bottomed plates (Falcon; Becton Dickinson Labware, Lincoln
Park, NJ) containing an equal volume of medium or medium sup-
plemented with 
 
A. fumigatus
 
 Ag (20 
 
m
 
g/ml). One set of plates
had been previously coated with 12 
 
m
 
g/ml hamster anti–mouse
CD3 mAb (clone 32C11). In the case of cultures containing wild-
type lung cells, additional wells were supplemented with a neu-
tralizing anti–IL-10 mAb (clone 2A5) at 10 
 
m
 
g/ml. Cultures were
incubated at 37
 
8
 
C in a humidified atmosphere with 5% CO
 
2
 
. Su-
pernatants were harvested 72 h later and stored at 
 
2
 
70
 
8
 
C until as-
sayed.
 
Measurement of Cytokine Levels in Culture Supernatants and BAL
Fluids and Determination of Serum Antibody Levels.
 
Cytokine lev-
els in BAL fluids and cell culture supernatants were determined
by two-site sandwich ELISA assays using the following Ab pairs
provided by Dr. J. Abrams and Dr. R.L. Coffman (DNAX): for
IFN-
 
g
 
, XMG1.2 and R504 polyclonal rabbit Ab; for IL-4, 11B11
and biotinylated BVD24G2.3; and for IL-5, TRFK5 and biotiny-
lated TRFK4. Before cytokine analysis, BAL supernatants were
concentrated six- to tenfold using Centricon 10 microconcentra-
tors (Amicon, Beverly, MA) with a 10,000 MW cut off. The re-
sults were then corrected for the degree of concentration.
Serum IgE titers were determined by two-site sandwich ELISA
assay using the mAb EM99 and NIP-conjugated rabbit anti–
mouse IgE (provided by Dr. R.L. Coffman). IgG1 and IgG2a
levels were determined using ELISA kits (Southern Biotechnol-
ogy, Birmingham, AL) as per manufacturer’s specifications. 
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Flow Cytometric Analysis of Intracellular Cytokine Production by
Lung Cells.
 
The assay was performed according to Openshaw et
al. (26) with slight modifications. In brief, cells recovered from
murine lungs as described above were treated with 0.9% ammo-
nium chloride to lyse erythrocytes, washed once with HBSS, re-
suspended in medium, and cultured at 4 
 
3
 
 10
 
6
 
 cells/ml in 6-well
flat-bottomed culture plates in 5-ml volumes. Cells from the
HDK1 Th1 cell line (produces IFN-
 
g
 
 but not IL-4), or from the
CDC25 Th2 cell line (produces IL-4 but not IFN-
 
g
 
) were in-
cluded as positive controls. All cell cultures were stimulated with
PMA (50 ng/ml) and ionomycin (500 ng/ml) for 2–2.5 h in the
presence of Fas–Ig fusion protein (5 
 
m
 
g/ml) (27) to prevent activa-
tion induced cell death. Brefeldin A (10 
 
m
 
g/ml) was then added
to the cultures. After 2 h of incubation, DNAse I (10 
 
m
 
g/ml,
Boehringer Mannheim, Mannheim, Germany) was added for a
few min. The cells were removed, washed with PBS, fixed with
formaldehyde (20–25 min), washed with PBS, and then stored in
FACS
 
Ò
 
 buffer (PBS, 1% BSA, 1 mM sodium azide) at 1–2 
 
3
 
 10
 
6
 
cells/ml at 4
 
8
 
C. The staining procedure was carried out at room
temperature within 24 h. The presence of intracellular IL-4 and
IFN-
 
g
 
 was detected with PE-conjugated 11B11 and FITC-con-
jugated AN18 mAb (provided by Dr. A. O’Garra; DNAX); PE-
and FITC-conjugated rat IgG1 isotype-matched Ab (PharMingen,
San Diego, CA) were used as negative controls. The cells were
treated for 10 min with permeabilization buffer (0.5% saponin
in FACS
 
Ò
 
 buffer) containing 25 
 
m
 
g/ml Fc blocking solution
(PharMingen), spun down, and then incubated with the anti-cyto-
kine or control Ab for 30 min. The cells were washed with per-
meabilization buffer for two times and with FACS
 
Ò
 
 buffer once
before staining with Tri-Color
 
Ô
 
-conjugated anti-mouse 
 
ab
 
TCR
mAb (Caltec, San Francisco), or hamster Ig control Ab (Caltec).
Samples were examined using a FACScan
 
Ò
 
 flow cytometer (Beck-
ton Dickinson, San Jose, CA). The data were analyzed using
CellQuest software (Becton Dickinson).
 
Airway Responsiveness.
 
Airway responsiveness to i.v. acetyl-
choline (ACh) challenge was measured as previously described (28).
In brief, mice were anesthetized with Nembutal sodium (Abbott
Laboratories, North Chicago, IL) administered i.p. at 0.04 mg/g
body weight. The tracheas were surgically exposed, cannulated
with a blunt-ended, 20-gauge angiocatheter, and connected to a
rodent ventilator (Harvard Apparatus, South Natick, MA). Mice
were ventilated with 100% oxygen at a rate of 150 breaths per
min and a tidal volume of 9 
 
m
 
l/g. Following paralysis with pan-
curonium bromide (4 
 
m
 
g/g; Gensia Laboratories, Irvine, CA),
i.v. access was established using a 27-gauge needle placed into a
tail vein and mice were placed into a rodent plethysmograph ca-
pable of determining tidal volume, airflow, dynamic compliance,
and transthoracic resistance continuously. Airway responses were
expressed as the amount of ACh required to double baseline trans-
thoracic resistance (PC200).
 
Microscopic Analysis.
 
Lungs from control and sensitized mice
were inflated with one ml of 10% (vol/vol) neutral buffered
formaldehyde. The inflated lungs were then placed into 10% (vol/
Figure 1. Sensitization protocols. Three different experimental proto-
cols were used involving two different strains of mice and two different
routes of priming. The same dose of A. fumigatus Ag without adjuvant
was delivered either i.n. or i.p. at the times indicated.
Figure 2. Cytokine levels made by in vitro restimulated lung cells from
WT and IL-102/2 mice. Lung cell suspensions were prepared from out-
bred mice 4–5 d after the second sensitization and from C57BL/6 mice
4–5 d after the final i.n. challenge. Lung cell suspensions were restimu-
lated with immobilized anti-CD3 in vitro. Closed dots represent data
from single sensitized WT mice; open dots represent data from WT lung
cell suspensions that were cultured in the presence of anti–IL-10 mAb.
Squares represent data from single sensitized IL-102/2 mice. Dashed lines
represent upper 95% confidence limits of cytokine levels secreted by re-
stimulated lung cells from unsensitized control mice. As data from unsen-
sitized WT and IL-102/2 mice were not statistically different they were
combined for the calculation of upper 95% confidence levels. 
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vol) neutral buffered formaldehyde. Tissues were routinely pro-
cessed, sectioned at 6 
 
m
 
m in a dorsal plane through the center of
the lung, and stained with hematoxylin and eosin (Sigma Chem.
Co.). Sections were analyzed by two independent examiners who
were blinded to treatment information.
 
Statistical Analysis.
 
Experimental groups were compared to each
other or to control groups using the nonparametric, unpaired,
two-tailed Mann-Whitney U test. For airway hyperresponsive-
ness, statistical analysis was performed using analysis of variance
(ANOVA) and the Bonferroni T test, on data expressed as the
logarithm of PC200. The statistical comparison of mortality seen in
different experimental groups was performed using Fisher’s Exact Test.
 
Result
 
Experimental Protocol.
 
WT and IL-10
 
2
 
/
 
2
 
 mice on the
C57BL/6 background were repeatedly primed i.p. (four
times) or i.n. (four times) and then given a final i.n. chal-
lenge (Fig. 1). Additionally, WT and IL-10
 
2
 
/
 
2
 
 mice on a
mixed C57BL/6 3 129Sv background (outbred) were re-
peatedly exposed to A. fumigatus Ag delivered only by the
i.n. route (Fig. 1) for a limited number of times (2 to 3) due
to the high mortality rate of the IL-102/2 mutants (see be-
low). In all experimental groups, the final i.n. challenge
was followed by a comparative analysis of cytokine produc-
tion, airway inflammation, antibody responses, airway physi-
ology, and histopathology.
Lung T cells from Sensitized IL-102/2 Mice Have Increased
Potential to Secrete Th2 and Th1 Cytokines In Vitro. Lung cells
from sensitized IL-102/2 and WT mice and from unsensi-
tized control mice were restimulated in vitro with immobi-
lized anti-CD3 mAb. Irrespective of the mouse strain or
the route of priming, lung T cells from sensitized IL-102/2
mice consistently produced higher levels of IL-4 and IL-5
than lung T cells from similarly treated WT mice (Fig. 2).
Furthermore, IL-102/2 cells also produced large quantities
of IFN-g, while WT cells produced low to undetectable
levels of IFN-g (Fig. 2). It seems unlikely that the de-
creased levels of IL-4, IL-5, and IFN-g produced by WT
T cells when compared with IL-102/2 T cells was due to
the suppressive effects of endogenously produced IL-10 in
the WT cultures, as the addition of neutralizing anti–IL-10
mAb did not lead to increased production of these cyto-
kines (Fig. 2).
Given that in vitro restimulation of IL-102/2 lung T cells
resulted in the enhanced production of Th2 (IL-4 and IL-5)
as well as Th1 (IFN-g) cytokines, we questioned whether
the absence of IL-10–mediated regulation led to the gener-
ation of polarized Th1 and Th2 cells and/or of Th0 cells
capable of producing both types of cytokines. Therefore,
abT cells from the lungs of nonsensitized controls and sen-
sitized IL-102/2 and WT mice were analyzed for their in-
tracellular cytokines by flow cytometry (26). T cells from
both WT and IL-102/2 mice displayed a similar pattern of
cytokine-producing cells irrespective of their strain or route
of priming. Representative data (Fig. 3) show that sensiti-
zation with A. fumigatus Ag invariably induced the genera-
tion of highly polarized IL-4–producing T cells in WT
mice as they represented a very small proportion of the
Figure 3. Flow cytometric
analysis of lung abT cells from
outbred and C57BL/6 mice for
intracellular IL-4 and IFN-g.
Lung cells were prepared from
outbred mice 4–5 d after the sec-
ond sensitization and from
C57BL/6 mice 4–5 d after the
final i.n. challenge. Lung cells
were briefly restimulated in vitro
with PMA and ionomycin as de-
scribed in Materials and Methods.
The cells were then triple-stained
with FITC-labeled anti–IFN-g
mAb, PE-labeled anti–IL-4 mAb,
and Tri-Color–labeled anti-
TCRab mAb. A separate cell
sample was stained with FITC-,
PE-, and Tri-Color–labeled iso-
type control antibodies. The gates
for positive labeling were set so
that less than 0.5% of the cells
were stained with the isotype
control antibodies. Lymphoid cells
were gated using forward and side
scatter. Within this gate, a sub-
gate was created for cells labeled
by the anti-abTCR mAb. The
abTCR-positive cells were then
examined for the presence of in-
tracellular cytokines. Four to five
mice were studied in each experimental group. Each dot plot represents a typical result. The median percentage of cells present in each of the four quad-
rants is represented in the corresponding cross section.1093 Grünig et al.
cytokine-producing cells present in the lungs of unsensi-
tized control mice. Because the same results were also ob-
tained with IL-102/2 cells, the generation of polarized Th2
cells was not dependent on the regulatory activities of IL-10.
Our data also show that exposure to A. fumigatus Ag did
not lead to an equivalent increase in Th0 cells or in polar-
ized Th1-like cells in the lungs of either IL-102/2 or WT
mice. These cells were present in approximately the same
proportion as they were in samples from unsensitized con-
trols. This latter finding was somewhat surprising in the
case of IL-102/2 mice because the experiments described
above demonstrated that their lung T cells were capable of
producing high levels of IFN-g after restimulation with
anti-CD3 mAb.
The absolute numbers of IL-4–producing and/or IFN-
g–producing cells recovered from the lungs of sensitized
C57BL/6 mice are presented in Fig. 4. We detected higher
numbers of cytokine-producing T cells in the lungs of
IL-102/2 mice primed i.p. when compared with similarly
treated WT mice. This particular comparison suggested that
increased T cell numbers in the lungs of IL-102/2 mice
may account for the higher levels of IL-4, IL-5, and IFN-g
detected in their lung cultures when restimulated in vitro
with anti-CD3 mAb (see Fig. 2). However, the number of
cytokine-producing T cells recovered from IL-102/2 mice
primed i.n. were roughly equivalent to the number recov-
ered from WT mice primed i.n. (Fig. 4), although mutant
cells consistently produced more IL-4, IL-5, and IFN-g af-
ter anti-CD3-stimulation (see Fig. 2). Therefore, it ap-
peared that sensitization with A. fumigatus Ag in the ab-
sence of IL-10 regulation, generated cytokine producing T
cells in larger numbers and/or T cells that had acquired the
inherent potential to produce larger quantities of cytokines.
Attempts to use A. fumigatus Ag to restimulate in vitro cyto-
kine production by lung cells from primed WT or IL-102/2
mice proved uninformative. A. fumigatus Ag-induced IL-5
production was low, IL-4 production was barely at the de-
tection limit, and IFN-g production was undetectable (data
not shown). Therefore, we focused on experiments de-
signed to measure A. fumigatus Ag-induced cytokine pro-
duction in vivo and to correlate these findings with num-
bers and types of inflammatory cells infiltrating the airways.
Outbred IL-102/2 Mice Showed Increased Cytokine Produc-
tion, Had Increased Airway Inflammation, and Experienced Mor-
bidity and Early Mortality Following Intranasal Sensitization.
Morbidity was evident after the second i.n. exposure to A.
fumigatus Ag. Compared with unsensitized controls, sensi-
tized IL-102/2 and WT mice lost weight. However, weight
loss was more pronounced in IL-102/2 mice (87.4 6 6.3%
of the initial wt; n 5 19) than in WT mice (93.2 6 3.0%,
n 5 17) (P 5 0.0014). Furthermore, IL-102/2 mice be-
came dehydrated and hypothermic. Approximately 2⁄3 of the
IL-102/2 mice died within 2–3 d after the third sensitiza-
tion, whereas mortality was rare in similarly treated WT mice
(Fig. 5). Because of the high mortality rate of sensitized
IL-102/2 mice, in vivo cytokine production and airway in-
flammation was assessed after the second sensitization. The
BAL fluids from IL-102/2 and WT mice contained equiva-
lent levels of IL-4 (Fig. 6). However, the same fluids from
IL-102/2 mice contained much higher levels of IL-5 and
IFN-g (Fig. 6). The cellular composition of BAL fluids re-
covered from IL-102/2 and WT mice was also different as
increased numbers of neutrophils were present in BAL flu-
ids of IL-102/2 mice (Fig. 6). In the BAL fluids of IL-102/2
mice, neutrophils (59 6 8%) predominated, while eosino-
phils (11 6 5%) were less frequent. In contrast, neutrophils
(19 6 3%), and eosinophils (25 6 10%) were present in ap-
proximately equal ratios in the BAL fluids of WT mice.
These results fit well with the fact that IL-102/2 mice ap-
peared to suffer from an uncontrolled acute inflammatory
response as evidenced by their high morbidity and mortal-
ity rates with increasing exposure to A. fumigatus. Although
eosinophils in the BAL samples from both groups were al-
ready increased well above the levels exhibited by unsen-
sitized controls, the numbers detected in the IL-102/2 sam-
ples were not as high as those in the WT samples. This finding
was surprising given that IL-5 production was higher in
IL-102/2 than in WT mice. One possible explanation for
this outcome is that the lung eosinophilia in IL-102/2 mice
was suppressed because of their simultaneous production of
IFN-g, which is known to inhibit the influx of eosinophils
during an inflammatory response (29–31).
IL-102/2 and WT Mice on the C57BL/6 Background
Showed Similar Levels of Cytokine Production and Airway Inflam-
mation Following Intranasal Sensitization. When C57BL/6
IL-102/2 and WT mice repeatedly inhaled A. fumigatus Ag
(five times), significant levels of IL-5 and low levels of IL-4
were detected in their BAL fluids as compared with unsen-
Figure 4. Absolute numbers of abT cells capable of making cytokines
in lungs of C57BL/6 mice. Lung cell suspensions were prepared from
C57BL/6 mice as described in the legend to Fig. 3. The absolute number
of lung cells recovered was determined before the brief restimulation with
PMA and ionomycin in vitro. The cells were then stained and analyzed as
described in the legend to Fig. 3. As numbers of lung abT cells capable of
making cytokines did not differ between unsensitized IL-102/2 (two sep-
arate pools of two lungs each) and WT (three separate pools of two lungs
each) control mice, data were combined for comparison to sensitized
groups. Data are reported as means 6 SD of 4–5 mice per sensitized
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sitized controls (Fig. 7). However, there were no differ-
ences between sensitized IL-102/2 and WT mice as equiv-
alent amounts of IL-4 and IL-5 were detected and IFN-g
levels were negligible. Moreover, the total number of cells
present in their BAL fluids were similar, including eosino-
phils (Fig. 7). In both groups, eosinophils (63 6 11%) pre-
dominated and neutrophils (0.3 6 0.4%) were rare. Fur-
thermore, when we examined crude lung cell suspensions,
IL-102/2 and WT mice had similar numbers of abT cells
capable of making IL-4, or IFN-g (see Fig. 4) and of abT
cells that made neither cytokine (data not shown).
C57BL/6 IL-102/2 Mice Primed Intraperitoneally Showed In-
creased IL-5 Production and Airway Inflammation Following In-
tranasal Challenge. A striking difference in the response of
C57BL/6 IL-102/2 as compared with WT mice was ob-
served when A. fumigatus Ag-priming was given i.p. (four
times) followed by a single i.n. challenge. IL-5 levels in BAL
fluids of IL-102/2 mice were significantly increased. Both
groups produced significant but similar levels of IL-4, and
IFN-g was extremely low or undetectable (Fig. 8). This cyto-
kine profile was consistent with the significantly increased
numbers of eosinophils in the BAL fluids of IL-102/2 mice
compared with similarly treated WT mice (Fig. 8). Similar
ratios of cell types with predominance of eosinophils (82.6 6
5.9%) were present in BAL fluids from WT and IL-102/2
mice primed i.p., suggesting qualitatively similar but quan-
titatively increased airway inflammation in IL-102/2 mice.
Furthermore, numbers of abT cells capable of producing
IL-4 and/or IFN-g (see Fig. 4) as well as numbers of abT
cells that made neither of these two cytokines (data not
shown) were significantly increased in lung tissues of IL-102/2
mice over levels seen in similarly treated WT mice.
Serum Antibody Titers and Airway Hyperresponsiveness Elic-
ited by A. fumigatus Ag Are Not Altered in IL-102/2 Mice.
Because of the sensitization-induced mortality in IL-102/2
outbred mice, serum antibody titers and airway responsive-
ness were evaluated in C57BL/6 mice only. Both IL-102/2
and WT mice exhibited increased total serum IgE and
IgG1 titers compared with unsensitized controls (Table 1).
Independent of the route of sensitization, IgE and IgG1 se-
rum titers in IL-102/2 mice were not statistically different
from those of WT mice. Neither IL-102/2 nor WT mice
showed increased IgG2a titers as compared with unsensi-
tized controls (data not shown). The antibody response
(IgE and IgG1) was always higher in mice primed by the
i.n. route as opposed to the i.p. route.
Figure 5. Mortality induced by sensitization with A. fumigatus Ag in
outbred mice. Survival curves are shown for IL-102/2 (n 5 18) and WT
(n 5 18) outbred mice sensitized with A. fumigatus Ag i.n.
Figure 6. Cytokine levels and numbers of neutrophils and eosinophils
in BAL fluids of outbred mice. BAL was performed 18–24 h after the sec-
ond i.n. sensitization. Dots and squares represent the data from single sen-
sitized WT or IL-102/2 mice, respectively. Dashed lines represent upper
95% confidence limits of data obtained from unsensitized control mice.
As data from unsensitized WT (n 5 3) or IL-102/2 (n 5 5) mice were not
statistically different, data from both groups were combined to calculate
upper 95% confidence limits.
Figure 7. Cytokine levels and numbers of eosinophils in BAL fluids
from C57BL/6 mice sensitized i.n. BAL was performed 18–24 h after the
final i.n. challenge. Dots and squares represent the data from single sensi-
tized WT or IL-102/2 mice, respectively. Dashed lines represent upper
95% confidence limits of data obtained from unsensitized control mice.
As data from unsensitized WT (n 5 7) or IL-102/2 (n 5 9) mice were not
statistically different, data from both groups were combined to calculate
upper 95% confidence limits.1095 Grünig et al.
Sensitization via either route elicited marked airway hy-
perresponsiveness (decreases in PC200) in both IL-102/2
and WT mice as compared with unsensitized controls (Ta-
ble 1). However, PC200 values were less variable in mice
primed by the i.n. route rather than by the i.p. route (Table
1). PC200 values measured in i.n. or i.p. primed IL-102/2
mice and similarly treated WT mice were statistically indis-
tinguishable (Table 1).
Lung Lesions in Sensitized WT and IL-102/2 Mice.
Lungs from unsensitized mice (Fig. 9 A) served as controls.
Microscopic changes in all groups of sensitized mice (Fig.
9, B–F), were qualitatively similar, but differed in severity.
Changes tended to be multifocal in less severely affected
mice, but coalesced and became more diffuse in severely
affected animals. Lung changes were generally character-
ized by inflammatory cell infiltrates adjacent to airways
(Fig. 9, open arrows) and blood vessels (closed arrows), and by
filling of alveoli with inflammatory cells and by thickening
of alveolar septa (arrowheads). The epithelium lining airways
in affected regions of lung was often hyperplastic and con-
tained numerous goblet cells. Inflammatory infiltrates adja-
cent to airways and blood vessels consisted primarily of
eosinophils, accompanied by smaller numbers of lympho-
cytes, macrophages, plasma cells, and neutrophils. Inflam-
matory cells within alveoli consisted of macrophages, lym-
phocytes, eosinophils, neutrophils, and multinucleated giant
cells. Alveolar septa in affected areas of lung were often
thickened by similar inflammatory cells, with the exception
of multinucleated giant cells, which were only seen within
alveoli.
Comparisons among the sensitized groups showed that
Figure 8. Cytokine levels and number of eosinophils in BAL fluids of
C57BL/6 mice primed i.p. and challenged i.n. BAL was performed 18–
24 h after the i.n. challenge. Dots and squares represent the data from sin-
gle sensitized WT or IL-102/2 mice, respectively. Dashed lines represent
upper 95% confidence limits of data obtained from unsensitized control
mice. As data from unsensitized WT (n 5 7) or IL-102/2 (n 5 9) mice
were not statistically different, data from both groups were combined to
calculate upper 95% confidence limits.
Table 1. Antibody Titers and Airway Responsiveness in Wild-type and IL-102/2 C57BL/6 Mice
Sensization
Wild type IL-102/2
Control i.n. i.p. and i.n. Control i.n. i.p. and i.n.
mg/ml
Serum IgE titers
Median 0.40 22.90* 3.60* 1.10 12.60* 2.30*
Range 0.2–2.1 3.8–80.7 1.3–7.9 0.3–2.7 1.9–52.7 1.3–4.0
n 1 6 1 51 11 6 1 11 1
mg/ml
Serum IgG1 titers
Median 0.08 0.97* 0.25* 0.11 1.05* 0.33*
Range 0.02–0.18 0.56–1.62 0.08–0.40 0.02–0.43 0.56–1.62 0.17–0.87
n 1 1 1 41 41 2 1 51 5
m g ACh/g bodyweight
PC200
Mean 2.24 0.22* 0.31* 1.13 0.30* 0.47*
Range 0.89–4.17 0.04–0.41 0.11–0.56 0.51–2.40 0.13–0.59 0.14–1.02
n 6 12 11 6 12 12
Antibody titers and airway responsiveness in WT and IL-102/2 C57BL/6 mice. Total serum antibody titers and airway responsiveness were exam-
ined 4–6 d after the final i.n. challenge of C57BL/6 mice primed i.n. or i.p. Airway responsiveness is expressed as PC200, the amount of ACh re-
quired to double baseline resistance. Antibody titers and PC200 values from unsensitized WT and IL-102/2 mice were not statistically different.
Baseline airway resistance was similar in sensitized and unsensitized mice (data not shown). For the statistical comparison between PC200 values from
experimental groups and controls, data from unsensitized IL-102/2 and WT mice were combined.
*Data are significantly different from unsensitized control mice (P ,0.05).1096 Role of IL-10 in Murine Allergic Bronchopulmonary Aspergillosis
alveolar lesions that developed in WT mice were least se-
vere in C57BL/6 mice (Fig. 9, B and C) and most severe in
outbred mice (Fig. 9 D). When comparisons were made
between IL-102/2 mice and their WT counterparts,
C57BL/6 IL-102/2 and WT mice sensitized i.n. developed
minimal to mild multifocal lesions that were very similar
(refer to representative section shown in Fig. 9 B). No dif-
ferences could be detected between these groups morpho-
logically. In contrast, C57BL/6 IL-102/2 mice primed i.p.
and challenged i.n. had more severe lesions than similarly
treated C57BL/6 WT mice (Fig 9, C and E), especially
with respect to the inflammatory infiltrates around airways and
blood vessels. In addition, changes in the C57BL/6 IL-102/2
mice were often more diffuse than in the similarly treated
C57BL/6 WT mice. Both WT and IL-102/2 outbred mice
sensitized i.n. developed the most severe alveolar changes
of all the experimental groups, and the changes in the IL-102/2
mice were more severe and diffuse than those seen in the
WT outbred mice (Fig. 9, D and F).
Discussion
We have examined the response to inhaled A. fumigatus
Ag in mice deficient in IL-10 production. Previous studies
have demonstrated that A. fumigatus Ag elicit a dominant
Th2-like response in the lungs of WT mice (21, 22). There
Figure 9. Lung lesions induced
by sensitization with A. fumigatus
Ag in outbred and C57BL/6 mice.
Sections were prepared from
formaldehyde-fixed lungs and
stained with hematoxylin and
eosin. Representative sections of a
lung from each group of mice are
shown (magnification, 3 80).
Lungs were removed 4 d after the
second i.n. sensitization of outbred
IL-102/2 (n 5 9) and WT (n 5 8)
mice. Lungs were removed 4–7 d
after the final i.n. challenge of
C57BL/6 mice that had been
primed i.n. or i.p. (n 5 6–9).
Open arrows point to peribron-
chial inflammation, closed arrows
point to perivascular inflammation,
and arrowheads point to alveolar
lesions. (A) As lung sections from
unsensitized WT and IL-102/2
mice were similar regardless of the
mouse strain, one representative
section is shown. (B) As lesions did
not differ between WT or IL-102/2
C57BL/6 mice sensitized i.n., only
one representative section is
shown. (C and E) Lungs from
C57BL/6 mice primed i.p. and
challenged i.n. (C) WT, (E)
IL-102/2. (D and F) Lungs from
outbred mice sensitized i.n. (D)
WT, (F) IL-102/2.1097 Grünig et al.
were two main hypotheses regarding the outcome of our
experiments. Sensitization of IL-102/2 mice would lead to
an increased macrophage and Th1 response (reviewed in
reference 19) or to increased Th1 and Th2 responses as ob-
served in human studies (reviewed in references 32, 33).
Our results showed clearly that the presence of IL-10 is not
necessary for the development of polarized IL-4–producing
Th2 cells as this population was consistently generated re-
gardless of the route of sensitization or the mouse strain
used. Furthermore, compared with WT mice, lung T cells
from sensitized IL-102/2 mice consistently secreted more
Th2 (IL-4 and IL-5) and Th1 (IFN-g) cytokines when re-
stimulated in vitro. Therefore, our findings are more in
agreement with those of human studies, suggesting that IL-10
negatively regulates both Th1 and Th2 responses to Ag
most probably by inhibiting antigen-presenting cells (11,
12, 32–36).
Although our in vitro studies have shown that sensitizing
IL-102/2 mice with A. fumigatus Ag led to the generation
of T cells capable of producing high levels of Th1 and Th2
cytokines, it was not clear how this potential would be
manifested in vivo where other regulatory factors could
come into play. Would increased Th1 and Th2 cytokine
production lead to more inflammation in the lungs? Alter-
natively, would IFN-g production antagonize potentially
increased IL-4 and IL-5 levels and protect mice from increased
eosinophilic inflammation of the lungs, IgE production,
and airway hyperresponsiveness (29–31)? We found that each
of the three different experimental protocols used provided
us with a different answer that appeared to be profoundly in-
fluenced by the genetic strain and the route of Ag-exposure.
The disease in outbred IL-102/2 mice sensitized i.n. ap-
pears to represent a mixture between ABPA and Aspergil-
lus-induced hypersensitivity pneumonitis. Although the in-
creased BAL–neutrophilia, BAL–IFN-g levels, morbidity,
and alveolar lesions in the sensitized IL-102/2 outbred
mice could be interpreted as typical for hypersensitivity
pneumonitis, the large numbers of eosinophils in the BAL
fluid of these mice and increased BAL–IL-5 levels do not fit
with the classification of hypersensitivity pneumonitis (2,
3). Although lung lesions in sensitized IL-102/2 outbred
mice were more extensive than those elicited in WT mice,
they were of similar quality. Therefore, we suspect that
mortality in IL-102/2 mice induced by repeated inhalation
of A. fumigatus Ag was caused by the uncontrolled produc-
tion of proinflammatory cytokines (e.g., IL-5, IFN-g),
which led to an acute shock-like state. This outcome was
also seen in IL-102/2 mice challenged with LPS (24) or in-
fected with Toxoplasma gondii (37).
In striking contrast with the outbred strain, C57BL/6
mice sensitized i.n. with A. fumigatus Ag developed mild
lung lesions. These changes, together with the pronounced
airway hyperresponsiveness and high IgE serum titers, are
typical for murine experimental asthma (28, 38). Surpris-
ingly, airway inflammation (BAL eosinophilia) that devel-
oped in the IL-102/2 mice was indistinguishable from that
of WT mice. Moreover, the BAL fluids of the IL-102/2
and WT mice contained equivalent amounts of IL-4 and IL-5
and no IFN-g. Therefore, it appears that IL-102/2 mice de-
veloped a dominant Th2 lung response of the same magni-
tude as that of WT mice. Despite the fact that IL-102/2
mice, repeatedly exposed to A. fumigatus Ag through inha-
lation, developed T cells with the capacity to secrete large
amounts of Th1 and Th2 cytokines when polyclonally acti-
vated in vitro, their in vivo response appeared to be just as
tightly regulated as that of WT mice.
Thus far, our data have illustrated the profound part that
genetic factors can play in lung disease induced by A. fumi-
gatus Ag. Even though the same Ag preparation was ad-
ministered i.n. to both outbred and C57BL/6 mice, the
outbred mice developed a complex disease resembling a
mixture of asthma and hypersensitivity pneumonitis, whereas
C57BL/6 mice developed primarily an asthma-like disease.
This adds to the body of evidence that genetic factors may
modify lung responses to A. fumigatus Ag. A previous study
has shown that inhalation of A. fumigatus Ag by mice from
two different mouse strains produced lung lesions of differ-
ent severity (39). Genetic susceptibility factors in the case
of human ABPA have been suggested by the familial oc-
currence of the disease (40, 41) and by an increased fre-
quency of mutations in the cystic fibrosis transmembrane
conductance regulator gene in ABPA patients (42). In addi-
tion, our studies showed that the inability to produce IL-10
leads to marked dysregulation and heightened disease on
the outbred but not the C57BL/6 background. A logical
conclusion would be that C57BL/6 mice have the inherent
ability to compensate for the absence of IL-10 by using
other negative regulatory mechanisms that could be pro-
vided by alveolar macrophages (43) or by TGF-b (44).
The specific mechanism evoked in C57BL/6 mice to
compensate for the absence of IL-10 regulation is unknown.
However, it is insufficient to prevent exaggerated eosino-
philia and IL-5 production in the airways and heightened
infiltration of the lungs with abT cells, when the route of
priming with A.fumigatus Ag is i.p. rather than i.n. This
priming protocol appeared to elicit strong Th2 responses in
both IL-102/2 and WT mice as inflammatory lung lesions
were of intermediate severity typical of experimental ABPA
(21) and BAL–IL-4 levels were high, whereas IFN-g was
undetectable. In this particular model of ABPA, the ab-
sence of IL-10 results in dysregulated IL-5 production, a
factor that appears to play a pivotal role in generating aller-
gic eosinophilic lung inflammation (38). In support of the
view that IL-10 can suppress IL-5–dependent eosinophilic
inflammation, IL-10 administered at the time of the Ag re-
call has been shown to diminish numbers of eosinophils in
the peritoneal cavity of primed BALB/c mice (45).
It has been reported previously that antibody responses
in IL-102/2 mice are not different from WT mice follow-
ing Ag stimulation (23). Our results confirm this observa-
tion as serum IgE and IgG1 titers elicited in C57BL/6
IL-102/2 and WT mice were roughly equivalent. Our re-
sults show additionally that endogenous IL-10 neither pro-
motes nor reduces airway hyperresponsiveness. Sensitiza-
tion elicited similar airway hyperresponsiveness in WT and
IL-102/2 mice. The equivalent antibody and airway responses1098 Role of IL-10 in Murine Allergic Bronchopulmonary Aspergillosis
in WT and IL-102/2 mice might reflect equivalent in vivo
IL-4 production, or elicitation of compensatory mechanisms
in IL-102/2 mice. Throughout our experiments, BAL–IL-4
levels were similar in sensitized IL-102/2 and WT mice,
supporting the former hypothesis.
In conclusion, our in vitro studies show that endogenous
IL-10 limits the potential to make large Th2 and Th1 re-
sponses elicited by A. fumigatus Ag in the lungs. In vivo,
endogenous IL-10 suppresses lung cytokine secretion and
airway inflammation induced by inhaled A. fumigatus Ag.
Therefore, IL-10 may be effective in ameliorating inflam-
mation in human allergic lung diseases. However, the suc-
cess of IL-10 therapy for allergic lung diseases may depend
on as yet undefined genetic factors and the route of exposure.
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